Adcetris 50 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCE3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,064
Award facts
- Contract value 100% obligated
- $36,063.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,063.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 50 mg vials of Adcetris, a specialty oncology pharmaceutical. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026, and will be performed at the vendor's Park Ridge, Illinois facility.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $499.9 billion ceiling value through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion DoD acquisition strategy designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group serves as a critical supplier for Department of Defense healthcare operations, with authorization to fulfill diverse pharmaceutical requirements including branded and generic prescription drugs, biologics, and medical consumables for the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSCE3?
SPE2DR26FSCE3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FSCE3 worth?
The government has obligated $36,064 on SPE2DR26FSCE3.
Is contract SPE2DR26FSCE3 an order under another contract?
Yes. SPE2DR26FSCE3 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCE3 competed?
The extent of competition for SPE2DR26FSCE3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award